Page 208 - Read Online

Page 6 of 9 Gholami et al. Mini-invasive Surg 2018;2:44 I http://dx.doi.org/10.20517/2574-1225.2018.44

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
3. Murthy R, Kamat P, Nuñez R, Salem R. Radioembolization of yttrium-90 microspheres for hepatic malignancy. Semin Intervent Radiol
2008;25:48-57.
4. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, et al. Recurrence and outcomes following hepatic resection, radiofrequency
ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818-25.
5. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-46.
6. Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg
2009;22:191-7.
7. Weiss L. Fundamental aspects of metastasis. New York: American Elsevier Pub. Co; 1976.
8. Hellinger MD, Santiago CA. Reoperation for recurrent colorectal cancer. Clin Colon Rectal Surg 2006;19:228-36.
9. Janout V, Kollárová H. Epidemiology of colorectal cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2001;145:5-10.
10. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006;12:895-904.
11. Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, et al. Treating metastatic cancer with nanotechnology. Nat Rev Cancer
2011;12:39-50.
12. Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H. Nanoparticles as drug delivery systems. Pharmacol Rep 2012;64:1020-37.
13. Agnihotri SA, Aminabhavi TM. Novel interpenetrating network chitosan-poly(ethylene oxide-g-acrylamide) hydrogel microspheres for
the controlled release of capecitabine. Int J Pharm 2006;324:103-15.
14. Sharma H. Role of external beam radiation therapy in management of hepatocellular carcinoma. J Clin Exp Hepatol 2014;4:S122-5.
15. dos Santos Giuberti C, de Oliveira Reis EC, Ribeiro Rocha TG, Leite EA, Lacerda RG, et al. Study of the pilot production process of
long-circulating and pH-sensitive liposomes containing cisplatin. J Liposome Res 2011;21:60-9.
16. Mijović J, Ristić S, Kenny J. Dynamics of six generations of PAMAM dendrimers as studied by dielectric relaxation spectroscopy.
Macromolecules 2007;40:5212-21.
17. Park J, Fong PM, Lu J, Russell KS, Booth CJ, et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin.
Nanomedicine 2009;5:410-8.
18. Rejinold NS, Sreerekha PR, Chennazhi KP, Nair SV, Jayakumar R. Jayakumar. Biocompatible, biodegradable and thermo-sensitive
chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery. Int J Biol Macromol 2011;49:161-72.
19. Suri SS, Fenniri H, SinghB. Nanotechnology-based drug delivery systems. J Occup Med Toxicol 2007;2:16.
20. van den Hoven JM, Van Tomme SR, Metselaar JM, Nuijen B, Beijnen JH, et al. Liposomal drug formulations in the treatment of
rheumatoid arthritis. Mol Pharm 2011;8:1002-15.
21. Akbarzadeh A, Samiei M, Davaran S. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine.
Nanoscale Res Lett 2012;7:144.
22. Gatoo MA, Naseem S, Arfat MY, Dar AM, Qasim K, et al. Physicochemical properties of nanomaterials: implication in associated toxic
manifestations. Biomed Res Int 2014;2014:498420.
23. Heiligtag FJ, Niederberger M. The fascinating world of nanoparticle research. Mater Today 2013;16:262-71.
24. Angioletti-Uberti S. Theory, simulations and the design of functionalized nanoparticles for biomedical applications: a soft matter
perspective. Npj Comput Mater 2017;3:48.
25. Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Available from: https://www.sciencedirect.com/science/
article/pii/S1878535217300990. [Last accessed on 14 Dec 2018]
26. Laroui H, Wilson DS, Dalmasso G, Salaita K, Murthy N, et al. Nanomedicine in GI. Am J Physiol Gastrointest Liver Physiol
2011;300:G371-83.
27. Laroui H, Dalmasso G, Nguyen HT, Yan Y, Sitaraman SV, et al. Drug-loaded nanoparticles targeted to the colon with polysaccharide
hydrogel reduce colitis in a mouse model. Gastroenterology 2010;138:843-53.
28. Sajeesh S, Bouchemal K, Sharma CP, Vauthier C. Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral